Henry Jardel

2.1k total citations
10 papers, 153 citations indexed

About

Henry Jardel is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henry Jardel has authored 10 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henry Jardel's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Henry Jardel is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Henry Jardel collaborates with scholars based in France and United States. Henry Jardel's co-authors include Philippe Moreau, Steven Le Gouill, Mohamad Mohty, Christophe Leux, Hervé Maisonneuve, Cyrille Touzeau, Françoise Kraeber‐Bodéré, Caroline Bodet‐Milin, P. Gries and Jean‐Luc Harousseau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Henry Jardel

10 papers receiving 151 citations

Peers

Henry Jardel

PFM

ONCOL

RNMI

PRM

NEURO

Jesse Shustik Canada

Carla Casulo United States

Henriette W Berenschot Netherlands

Anupkumar George Australia

Allison Barraclough Australia

Julie Lisano United States

Joel Wight Australia

Susan J. McCall United States

Mitul Gandhi United States

Armando López Guillermo Spain

Jesse Shustik Canada

Henry Jardel

114 ×1.0

PFM

78 ×1.2

ONCOL

16 ×0.4

RNMI

16 ×0.4

PRM

27 ×0.9

NEURO

Citations per year, relative to Henry Jardel Henry Jardel (= 1×) peers Jesse Shustik

Countries citing papers authored by Henry Jardel

Since Specialization

Citations

This map shows the geographic impact of Henry Jardel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Jardel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Jardel more than expected).

Fields of papers citing papers by Henry Jardel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Jardel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Jardel. The network helps show where Henry Jardel may publish in the future.

Co-authorship network of co-authors of Henry Jardel

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Jardel. A scholar is included among the top collaborators of Henry Jardel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Jardel. Henry Jardel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Bourcier, Jessie, Thomas Gastinne, Christophe Leux, et al.. (2016). Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience. Annals of Hematology. 95(8). 1287–1293. 9 indexed citations

Hanf, Matthieu, David Chiron, Sophie de Visme, et al.. (2016). The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma. BMC Cancer. 16(1). 802–802. 7 indexed citations

Loirat, Marion, Patrice Chevallier, Christophe Leux, et al.. (2014). Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center. Annals of Oncology. 26(2). 386–392. 30 indexed citations

Néel, A., A. Masseau, Bernard Henry, et al.. (2013). Efficacité et tolérance à long terme de l’Anakinra dans le syndrome de Schnitzler : étude rétrospective multicentrique. La Revue de Médecine Interne. 34. A31–A31. 1 indexed citations

Rodon, Philippe, Cyrille Hulin, Brigitte Pegourié, et al.. (2012). Bendamustine, Bortezomib and Dexamethasone (BVD) in Elderly Patients with Multiple Myeloma in First Relapse: Updated Results of the Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial. Blood. 120(21). 4044–4044. 5 indexed citations

Rodon, Philippe, Cyrille Hulin, Brigitte Pegourié, et al.. (2012). Bendamustine, bortezomib, and dexamethasone (BVD) in elderly patients with relapsed/refractory multiple myeloma (RRMM): The Intergroupe Francophone du Myélome (IFM) 2009-01 protocol.. Journal of Clinical Oncology. 30(15_suppl). 8014–8014. 3 indexed citations

Bodet‐Milin, Caroline, Cyrille Touzeau, Christophe Leux, et al.. (2010). Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group. European Journal of Nuclear Medicine and Molecular Imaging. 37(9). 1633–1642. 71 indexed citations

Bodet‐Milin, Caroline, Philippe Moreau, Thomas Gastinne, et al.. (2010). Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients. Bone Marrow Transplantation. 46(3). 393–399. 19 indexed citations

Hunault, Mathilde, Catherine Ternisien, Henry Jardel, et al.. (2001). [Acquired von Willebrand disease and lymphoproliferative syndromes].. PubMed. 30(5). 209–12. 6 indexed citations

10.

Ifrah, Norbert, V. Rohmer, Jean‐Paul Saint‐André, et al.. (1988). [Primary lymphoma of the thyroid gland. Diagnostic and therapeutic discussion. Apropos of 4 cases].. PubMed. 139(5). 344–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact